Where Will RocketLab Stock Be In 5 Years?
Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…
Sell
8
HDL Quote, Financials, Valuation and Earnings
Last price:
$18.98
Seasonality move
:
-20.2%
Day range:
$18.63 - $18.70
52-week range:
$13.94 - $30.00
Dividend yield:
0%
P/E ratio:
31.28x
P/S ratio:
1.46x
P/B ratio:
3.00x
Volume:
1.1K
Avg. volume:
1.7K
1-year change:
17.17%
Market cap:
$1.1B
Revenue:
$778.3M
EPS (TTM):
$0.60
Analysts' Opinion
-
Consensus RatingSuper Hi International Holding has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.10, Super Hi International Holding has an estimated upside of 19.96% from its current price of $18.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 100% downside risk from its current price of $18.70.
Fair Value
-
According to the consensus of 3 analysts, Super Hi International Holding has 19.96% upside to fair value with a price target of $22.10 per share.
HDL vs. S&P 500
-
Over the past 5 trading days, Super Hi International Holding has underperformed the S&P 500 by -8.24% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Super Hi International Holding does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Super Hi International Holding has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Super Hi International Holding reported revenues of $197.8M.
Earnings Growth
-
Super Hi International Holding has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Super Hi International Holding reported earnings per share of $0.20.
Enterprise value:
848.6M
EV / Invested capital:
--
Price / LTM sales:
1.46x
EV / EBIT:
14.34x
EV / Revenue:
1.08x
PEG ratio (5yr expected):
0.31x
EV / Free cash flow:
7.36x
Price / Operating cash flow:
9.96x
Enterprise value / EBITDA:
6.08x
Gross Profit (TTM):
$273.3M
Return On Assets:
5.92%
Net Income Margin (TTM):
4.85%
Return On Equity:
11.23%
Return On Invested Capital:
11.23%
Operating Margin:
3.65%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | $713.1M | $788.4M | $187.6M | $197.8M | |
| Gross Profit | -- | $236.7M | $273.3M | $61.2M | $60.8M | |
| Operating Income | -- | $43.9M | $61.3M | $11.9M | $7.2M | |
| EBITDA | -- | $109.4M | $139.6M | $21M | $37.8M | |
| Diluted EPS | -- | $0.30 | $0.60 | -$0.10 | $0.20 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $221.1M | $324.3M | |
| Total Assets | -- | -- | -- | $567.1M | $684.7M | |
| Current Liabilities | -- | -- | -- | $123.6M | $124.7M | |
| Total Liabilities | -- | -- | -- | $293.4M | $316.9M | |
| Total Equity | -- | -- | -- | $273.7M | $367.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $110.3M | $115.4M | $24M | $19.7M | |
| Cash From Investing | -- | -$68.1M | -$9.7M | -$73.5M | -$55.6M | |
| Cash From Financing | -- | -$45M | $10.3M | -$12.5M | -$14.8M | |
| Free Cash Flow | -- | $77.4M | $115.4M | $24M | $19.7M | |
HDL
Sector
Market Cap
$1.1B
$418.8M
Price % of 52-Week High
62.33%
71.49%
Dividend Yield
0%
0%
Shareholder Yield
--
4.02%
1-Year Price Total Return
17.17%
-11.46%
Beta (5-Year)
--
0.780
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$19.92
200-day SMA
Sell
Level
$21.12
Bollinger Bands (100)
Sell
Level
20.2 - 24.68
Chaikin Money Flow
Sell
Level
-965.6K
20-day SMA
Sell
Level
$20.02
Relative Strength Index (RSI14)
Sell
Level
34.50
ADX Line
Sell
Level
15.33
Williams %R
Buy
Level
-97.0464
50-day SMA
Sell
Level
$20.68
MACD (12, 26)
Sell
Level
-0.46
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
477.9K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (0.3165)
Buy
Beneish M-Score
(Annual)
Level (-2.5405)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.3678)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
Stock Forecast FAQ
In the current month, HDL has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HDL average analyst price target in the past 3 months is $22.10.
-
Where Will Super Hi International Holding Stock Be In 1 Year?
According to analysts, the consensus estimate is that Super Hi International Holding share price will rise to $22.10 per share over the next 12 months.
-
What Do Analysts Say About Super Hi International Holding?
Analysts are divided on their view about Super Hi International Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Super Hi International Holding is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is Super Hi International Holding's Price Target?
The price target for Super Hi International Holding over the next 1-year time period is forecast to be $22.10 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HDL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Super Hi International Holding is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HDL?
You can purchase shares of Super Hi International Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Super Hi International Holding shares.
-
What Is The Super Hi International Holding Share Price Today?
Super Hi International Holding was last trading at $18.98 per share. This represents the most recent stock quote for Super Hi International Holding. Yesterday, Super Hi International Holding closed at $18.70 per share.
-
How To Buy Super Hi International Holding Stock Online?
In order to purchase Super Hi International Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is MO dividend Worth It?
Altria Group (NYSE: MO) is paying investors $1.02 a share…
How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
37
RGC alert for Jun 21
Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.
Buy
83
GMS alert for Jun 21
GMS [GMS] is up 23.79% over the past day.
Buy
57
QNTM alert for Jun 21
Quantum BioPharma [QNTM] is up 13.82% over the past day.
